KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsReceivables - NetReceivables - OtherShort-Term Debt repayments
Ratios

QuidelOrtho (QDEL) EBIAT (2021 - 2025)

QuidelOrtho's EBIAT history spans 4 years, with the latest figure at -$178.4 million for Q4 2024.

  • For Q4 2024, EBIAT fell 2648.57% year-over-year to -$178.4 million; the TTM value through Dec 2024 reached -$2.1 billion, down 20216.83%, while the annual FY2025 figure was -$1.1 billion, 44.84% up from the prior year.
  • EBIAT for Q4 2024 was -$178.4 million at QuidelOrtho, down from -$19.9 million in the prior quarter.
  • Across five years, EBIAT topped out at $479.9 million in Q2 2022 and bottomed at -$1.7 billion in Q1 2024.
  • The 4-year median for EBIAT is $13.0 million (2021), against an average of -$83.8 million.
  • The largest annual shift saw EBIAT grew 1.05% in 2022 before it crashed 3595.9% in 2024.
  • A 4-year view of EBIAT shows it stood at $215.7 million in 2021, then crashed by 91.1% to $19.2 million in 2022, then crashed by 63.54% to $7.0 million in 2023, then plummeted by 2648.57% to -$178.4 million in 2024.
  • Per Business Quant, the three most recent readings for QDEL's EBIAT are -$178.4 million (Q4 2024), -$19.9 million (Q3 2024), and -$147.7 million (Q2 2024).